Dag Elmfeldt

12.7k total citations · 3 hit papers
94 papers, 9.3k citations indexed

About

Dag Elmfeldt is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Dag Elmfeldt has authored 94 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Cardiology and Cardiovascular Medicine, 20 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Surgery. Recurrent topics in Dag Elmfeldt's work include Blood Pressure and Hypertension Studies (41 papers), Hormonal Regulation and Hypertension (13 papers) and Heart Rate Variability and Autonomic Control (10 papers). Dag Elmfeldt is often cited by papers focused on Blood Pressure and Hypertension Studies (41 papers), Hormonal Regulation and Hypertension (13 papers) and Heart Rate Variability and Autonomic Control (10 papers). Dag Elmfeldt collaborates with scholars based in Sweden, Italy and Germany. Dag Elmfeldt's co-authors include Hans Wedel, Alberto Zanchetti, Lennart Hansson, Stevo Julius, S. Westerling, S. George Carruthers, Björn Dahlöf, Joël Ménard, K. H. Rahn and Lars Wilhelmsen and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Dag Elmfeldt

92 papers receiving 8.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial

1998 4.0k citations Lennart Hansson, Alberto Zanchetti et al. profile →
The Study on Cognition and Prognosis in the Elderly (SCOPE)

2003 1.0k citations Hans Lithell, Lennart Hansson et al. Journal of Hypertension profile →
EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION

1981 781 citations Åke Hjalmarson, Johan Herlitz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dag Elmfeldt Sweden	35	7.1k	3.0k	1.4k	1.1k	824	94	9.3k
Joël Ménard France	35	5.7k 0.8×	3.2k 1.1×	1.6k 1.1×	999 0.9×	769 0.9×	143	9.4k
Björn Dahlöf Sweden	41	8.6k 1.2×	3.0k 1.0×	1.5k 1.0×	716 0.7×	941 1.1×	94	10.7k
Per Omvik Norway	27	6.8k 1.0×	3.1k 1.1×	1.1k 0.8×	677 0.6×	952 1.2×	125	8.7k
S. George Carruthers Canada	29	4.1k 0.6×	2.0k 0.7×	1.1k 0.8×	945 0.9×	492 0.6×	77	6.4k
Gastone Leonetti Italy	39	5.5k 0.8×	1.8k 0.6×	935 0.6×	501 0.5×	840 1.0×	197	7.0k
W.J. Elliott United States	46	6.1k 0.9×	2.4k 0.8×	1.3k 0.9×	637 0.6×	1.1k 1.3×	390	10.1k
Bengt Scherstén Sweden	38	2.9k 0.4×	2.6k 0.9×	1.2k 0.8×	643 0.6×	663 0.8×	164	6.6k
DG Beevers United Kingdom	47	5.1k 0.7×	1.8k 0.6×	1.3k 0.9×	446 0.4×	812 1.0×	180	9.1k
W. H. Birkenhäger Netherlands	30	4.6k 0.6×	1.9k 0.6×	726 0.5×	521 0.5×	897 1.1×	100	6.6k
K. H. Rahn Germany	22	4.0k 0.6×	1.9k 0.6×	1.0k 0.7×	702 0.7×	563 0.7×	73	5.6k

Countries citing papers authored by Dag Elmfeldt

Since Specialization

Citations

This map shows the geographic impact of Dag Elmfeldt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dag Elmfeldt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dag Elmfeldt more than expected).

Fields of papers citing papers by Dag Elmfeldt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dag Elmfeldt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dag Elmfeldt. The network helps show where Dag Elmfeldt may publish in the future.

Co-authorship network of co-authors of Dag Elmfeldt

This figure shows the co-authorship network connecting the top 25 collaborators of Dag Elmfeldt. A scholar is included among the top collaborators of Dag Elmfeldt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dag Elmfeldt. Dag Elmfeldt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elmfeldt, Dag, et al.. (2015). General Aspects of Secondary Prevention after Myocardial Infarction. Advances in cardiology. 94–104.

Karlson, Björn W., Sofia Zetterstrand, Bertil Olofsson, & Dag Elmfeldt. (2009). A dose-response analysis of candesartan-hydrochlorothiazide combination therapy in patients with hypertension. Blood Pressure. 18(3). 149–156. 12 indexed citations

Al‐Windi, Ahmad, Dag Elmfeldt, & Kurt Svärdsudd. (2004). The influence of sociodemographic characteristics on health care utilisation in a Swedish municipality. Upsala Journal of Medical Sciences. 109(1). 33–42. 6 indexed citations

Papademetriou, Vasilios, Csaba Farsang, Dag Elmfeldt, et al.. (2004). Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension. Journal of the American College of Cardiology. 44(6). 1175–1180. 140 indexed citations

Al‐Windi, Ahmad, Dag Elmfeldt, & Kurt Svärdsudd. (2003). Determinants of drug utilisation in a Swedish municipality. Pharmacoepidemiology and Drug Safety. 13(2). 97–103. 22 indexed citations

Lithell, Hans, Lennart Hansson, Ingmar Skoog, et al.. (2003). The Study on Cognition and Prognosis in the Elderly (SCOPE). Journal of Hypertension. 21(5). 875–886. 1033 indexed citations breakdown →

Elmfeldt, Dag, et al.. (1997). Candesartan cilexetil, a new generation angiotensin II antagonist, provides dose dependent antihypertensive effect.. PubMed. 11 Suppl 2. S49–53. 64 indexed citations

Gordon, Richard D., S. A. Klemm, Terry J. Tunny, John Wicks, & Dag Elmfeldt. (1995). Effects of Felodipine, Metoprolol and Their Combination on Blood Pressure at Rest and During Exercise and on Volume Regulatory Hormones in Hypertensive Patients. Blood Pressure. 4(5). 300–306. 3 indexed citations

Olsson, Greger, Jaakko Tuomilehto, G Berglund, et al.. (1991). Primary Prevention of Sudden Cardiovascular Death in Hypertensive Patients: Mortality Results From the MAPHY Study. American Journal of Hypertension. 4(2 Pt 1). 151–158. 60 indexed citations

10.

Tuomilehto, Jaakko, et al.. (1990). Coronary Artery Disease can be Prevented by Antihypertensive Therapy. Journal of Cardiovascular Pharmacology. 16. S75–S76. 4 indexed citations

11.

Hedner, Thomas, Dag Elmfeldt, H. von Schenck, Eva Sjögren, & Ulf Smith. (1987). Glucose tolerance in hypertensive patients during treatment with the calcium antagonist, felodipine.. British Journal of Clinical Pharmacology. 24(2). 145–149. 7 indexed citations

12.

Elmfeldt, Dag, et al.. (1987). Pharmacokinetics and Haemodynamics of Felodipine in Hypertensive Patients Treated Concomitantly with a β-Blocker. Drugs. 34(Supplement 3). 30–30. 1 indexed citations

13.

Hedner, Thomas, et al.. (1986). Treatment of essential hypertension with felodipine in combination with a diuretic. European Journal of Clinical Pharmacology. 30(2). 133–139. 31 indexed citations

14.

Wiklund, Ingela, H Sanne, Dag Elmfeldt, A Vedin, & Claes Wilhelmsson. (1984). Emotional Reaction, Health Preoccupation and Sexual Activity Two Months After a Myocardial Infarction. Journal of Rehabilitation Medicine. 16(2). 47–56. 29 indexed citations

15.

Herlitz, Johan, Dag Elmfeldt, Åke Hjalmarson, et al.. (1983). Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarction. The American Journal of Cardiology. 51(8). 1282–1288. 72 indexed citations

16.

Wiklund, Olov, Lars Wilhelmsen, Dag Elmfeldt, et al.. (1980). Alpha-lipoprotein cholesterol concentration in relation to subsequent myocardial infarction in hypercholesterolemic men. Atherosclerosis. 37(1). 47–53. 27 indexed citations

17.

Elmfeldt, Dag, Claes Wilhelmsson, A Vedin, Gösta Tibblin, & Lars Wilhelmsen. (1976). Characteristics of Representative Male Survivors of Myocardial Infarction Compared with Representative Population Samples. Acta Medica Scandinavica. 199(1-6). 387–398. 22 indexed citations

18.

Vedin, A, Claes Wilhelmsson, Dag Elmfeldt, et al.. (1975). Deaths and Non‐fatal Reinfarctions during Two Years' Follow‐up after Myocardial Infarction. Acta Medica Scandinavica. 198(1-6). 353–364. 44 indexed citations

19.

Vedin, J. A., Claes Wilhelmsson, Dag Elmfeldt, et al.. (1973). Sudden death: Identification of high risk groups. American Heart Journal. 86(1). 124–132. 20 indexed citations

20.

Elmfeldt, Dag & Lars Wilhelmsen. (1971). [Myocardial infarction--morbidity, mortality and disablement].. PubMed. 68(33). 3705–10. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact